Study Finds Blood Test May Detect Early Breast Cancer, Predict Recurrence
Israeli researchers report a blood test using epigenetic signatures in circulating nucleosomes can detect early-stage breast cancer and predict recurrence risk more accurately than tissue biopsies, according to a study in Nature.